Skip to main content

The pharmacy day | A question to investigate

The medicine may be familiar. The process can still be confusing.

For someone using repeat medicines, the pharmacy journey can involve a request, authorisation, electronic transmission, preparation and collection. When the stages are unclear, the person may contact several teams or visit before the prescription is ready. Each contact creates work, but the more important problem is uncertainty about what will happen next. A useful operational review identifies where that uncertainty begins and who is able to resolve it.

Film credits

In the conversation.

NEUVIOR and our founder’s perspectives have appeared across science, business and technology publications.

University of Warwick IATL | AI Ethics NowpharmaphorumTechRadar ProET PharmaFinancial TimesPharmaceutical TechnologyPharmaTimesManufacturing ChemistDigital HealthDaily BusinessTheBusinessDesk.comStartups MagazineInsider MediaYorkshire PostYork PressBusinessCloud

Reporting, commentary, letters and podcast appearances | Read each feature for its format and source.

Distinguish the request from the prescription

NHS guidance describes how repeat requests in the NHS App are sent to the surgery for sign-off and how EPS transfers prescription information to dispensers (NHS England Digital, n.d.; NHS England Digital, n.d.). Those are different events. A request submitted by the person is not the same as a prescription received by the pharmacy, and neither confirms that medicines are ready for collection. Clear explanations of these stages can support a better journey without promising control over decisions held by another organisation.

Categorise the reason for repeated contact

A person may be asking whether the surgery authorised the request, whether the pharmacy received it, whether an item is available or when collection is possible. Keep those categories separate. The pharmacy should not be expected to resolve a prescriber's decision, and the GP team should not have to answer a local collection question it cannot see. Map the information each party actually holds and the responsibility it can reasonably accept.

Test communication at one boundary

A proposed PHARMORIS evaluation could focus on a recurring non-clinical status question between a pharmacy and a local practice. Compare ordinary practice with a clearer, agreed explanation of the relevant stages and contact route. Begin with aggregate enquiry categories, repeat contacts and staff time. A first review does not require copying prescription content into a new system or claiming a live EPS integration. Any future technical connection would need its own demonstrated capability and authorisation.

Put the four status questions side by side

Was the request made, was it authorised, was the prescription received and is collection possible? Map which organisation can answer each question using its existing information. Then classify repeated enquiries against those stages. This makes the improvement opportunity concrete: clearer expectations, a reliable local handover or a demonstrated technical need. It avoids promising a universal tracking experience before the necessary visibility, permissions and operational responsibilities have been established.

Find the gap between organisations.

A useful handover is information that reaches someone able to act. Explore a constructed case before deciding what to measure.

People repeat a status question across the pharmacy and practice.

Makes a shared operational problem inspectable without claiming that referral volume proves prevented readmissions.

What would we need to understand?

  • Episodes entering the defined cohort
  • Agreed handovers and recorded progression
  • Elapsed time bands and reasons for waiting
  • Clarification effort and accountable next owner

Constructed decision example | No customer results are shown.

NHS England Digital (n.d.) | NHS England Digital (n.d.)

Use the right comparison period

Repeat demand can vary with holidays, opening hours and prescription cycles. Record these factors and compare periods with a credible operating relationship. Observe whether contact falls because people understand the journey or because they find it harder to reach someone. Include staff feedback on unexpected consequences. A narrow, well-explained result is more useful than a large percentage reduction whose denominator combines several different reasons for contact.

Count shared workload rather than isolated savings

If a pharmacy supplies a clearer answer, the practice may receive fewer queries; if the pharmacy merely redirects callers, it may shift the same work upstream. Measure both sides where participation and data permit. Staff minutes are a capacity measure, not automatically a cash saving. A better patient experience may be the main result. If the proposed case includes fewer unnecessary journeys or more reliable collection, those outcomes need to be observed rather than inferred from fewer telephone calls.

Keep choice and clinical review intact

An operational improvement should not pressure someone to change pharmacy, order earlier than appropriate or avoid a necessary medication review. Keep professional decisions and established nomination standards within the responsible services' arrangements. Stop if messages create false certainty, hide missing prescriptions or discourage people from seeking help when medicines are running out. The aim is a clearer next step, not an automated answer that closes an enquiry while leaving the underlying need unresolved.

NEUVIOR Data Analysis

A source.
A question.
A clearer decision.

Useful intelligence keeps its evidence attached.

Our public analysis connects a defined question with named sources, reporting periods and methods. Each source below shows the work available today and the access still needed.

Published-data analysis, research hypotheses and evidence studies are distinct kinds of work. Their meaning should remain clear as the programme grows.

NHS Business Services Authority | Annual

Prescription Cost Analysis

How does activity differ from ingredient-cost concentration?

Analysis available

Official source

NHS Business Services Authority | Monthly

English Prescribing Dataset with SNOMED Code

Which product and organisational patterns merit a closer investigation?

Metadata retrieved

Official source

Medicines and Healthcare products Regulatory Agency | Event-driven; monthly roundup also published

Medicines and device safety communications

Which official communication should a responsible team read next?

Snapshot retrieved

Official source

NHS Business Services Authority and NHS England | Weekly

Dictionary of medicines and devices

Can the same product identity be followed consistently across sources?

Access review

Official source

Explore NEUVIOR Data Analysis

Start with the question staff hear every day

Bring the repeated enquiry, the answer the team can currently provide and the point where it loses visibility. We can examine whether a scoped assessment would identify a useful change and what evidence would justify continuing. PHARMORIS is being developed around medicines decisions and accountable follow-through. A familiar local problem can be an important starting point when the proposed improvement is specific, the comparison is fair and the benefit is described honestly.

Sources and scope

NHS England Digital | Electronic Prescription Service | NHS England Digital | Prescriptions in the NHS App

NHS England Digital (n.d.) Prescriptions in the NHS App. Available at: https://digital.nhs.uk/services/nhs-app/nhs-app-features/prescriptions-in-the-nhs-app (Accessed: 14 October 2026).

NHS England Digital (n.d.) Electronic Prescription Service. Available at: https://digital.nhs.uk/services/electronic-prescription-service (Accessed: 14 October 2026).

Another useful angle.

NEWSPerspectives & features